NLRC4 and myeloid sarcoma: Moreover, as gain-of-function genetic variants of the NLRP3 (e.g., Q705K) and NLRC4 inflammasomes associate with a more severe MS course, a constitutive NLRP3 inflammasome activation could be a risk factor for clinical MS presentation [396].